Expertise Term: mammalian target of rapamycin (mTOR)
 NameInstitutionRole
Haugh, JasonNC State UniversityEditorial Board Member
 
 
Name: Haugh, Jason
Role: Editorial Board Member
Email: jason_haugh@ncsu.edu
Institution: NC State University
Department: Chemical & Biomolecular Engineering
Subject Categories:
Expertise Terms: Akt PKB, cell migration, extracellular-signal-regulated kinase (ERK), integrin, mammalian target of rapamycin (mTOR), mathematical modeling, mechanotransduction, phosphatidylinositide 3-kinase (PI 3-kinase), protein phosphorylation, receptor tyrosine kinase
Jacinto, EstelaRutgers Robert Wood Johnson Medical School Department of Biochemistry and Molecular BiologyEditorial Board Member
 
 
Name: Jacinto, Estela
Role: Editorial Board Member
Email: jacintes@rwjms.rutgers.edu
Institution: Rutgers Robert Wood Johnson Medical School Department of Biochemistry and Molecular Biology
Department: Biochemistry and Molecular Biology
Subject Categories:
Expertise Terms: Akt PKB, mammalian target of rapamycin (mTOR), metabolism, post-translational modification (PTM), protein phosphorylation, protein synthesis, RNA binding protein, translation control
Matarese, GiuseppeUniversity of Naples Federico IIEditorial Board Member
 
 
Name: Matarese, Giuseppe
Role: Editorial Board Member
Email: giuseppe.matarese@unina.it
Institution: University of Naples Federico II
Department: Dipartimento di Medicina Molecolare e Biotecnologie Mediche
Subject Categories:
Expertise Terms: adipose tissue, autoimmune disease, immunology, leptin, mammalian target of rapamycin (mTOR), metabolism, multiple sclerosis, neuroimmunology, signal transduction, T-cell
Murray, PeterMax-Planck-Institut für BiochemieEditorial Board Member
 
 
Name: Murray, Peter
Role: Editorial Board Member
Email: murray@biochem.mpg.de
Institution: Max-Planck-Institut für Biochemie
Department: Immunoregulation Group
Subject Categories:
Expertise Terms: amino acid, cellular immune response, cytokine action, immunology, indoleamine-pyrrole 2,3-dioxygenase (IDO1), macrophage, mammalian target of rapamycin (mTOR), STAT3, tryptophan, tumor microenvironment
Ramesh, VijayaMassachusetts General HospitalEditorial Board Member
 
 
Name: Ramesh, Vijaya
Role: Editorial Board Member
Email: ramesh@helix.mgh.harvard.edu
Institution: Massachusetts General Hospital
Department: Center for Genomic Medicine
Subject Categories:
Expertise Terms: cell signaling, genetic disease, mammalian target of rapamycin (mTOR), molecular bases of disease, mTOR complex (mTORC), S6 kinase, signal transduction, target of rapamycin (TOR), TOR complex (TORC), tuberous sclerosis complex (TSC)
Sarbassov, DosNazarbayev UniversityEditorial Board Member
 
 
Name: Sarbassov, Dos
Role: Editorial Board Member
Email: dos.sarbassov@nu.edu.kz
Institution: Nazarbayev University
Department: Biology
Subject Categories:
Expertise Terms: Akt PKB, mammalian target of rapamycin (mTOR), nuclear pore, protein kinase, protein synthesis, ribosomal RNA processing (rRNA processing), ribosome assembly, rRNA processing, TOR complex (TORC), translation control
Sundaresan, NagalingamIndian Institute of ScienceEditorial Board Member
 
 
Name: Sundaresan, Nagalingam
Role: Editorial Board Member
Email: rsundaresan@iisc.ac.in
Institution: Indian Institute of Science
Department: Microbiology and Cell Biology
Subject Categories:
Expertise Terms: acetylation, ADP-ribosylation, aging, Akt PKB, c-Jun N-terminal kinase (JNK), cardiac hypertrophy, cardiac metabolism, cardiac muscle, cardiomyocyte, cardiomyopathy, cardiovascular, cardiovascular disease, cell biology, cell death, cell signaling, cellular senescence, chromatin remodeling, diabetes, fibroblast, fibrosis, gene regulation, gene transcription, glycogen synthase kinase 3 (GSK-3), heart failure, histone acetylase, histone acetylation, histone deacetylase (HDAC), histone modification, insulin receptor substrate 1 (IRS-1), insulin resistance, insulin-like growth factor (IGF), mammalian target of rapamycin (mTOR), molecular bases of disease, muscle atrophy, muscle hypertrophy, muscle physiology, muscle regeneration, myocardial infarction, nicotinamide adenine dinucleotide (NAD), oxidative stress, post-translational modification (PTM), sirtuin, sirtuin 1 (SIRT1), transforming growth factor beta (TGF-B), Type 2 diabetes, Wnt signaling